China Sxt Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.48

SXTC Stock  USD 0.39  0.01  2.63%   
China SXT's future price is the expected price of China SXT instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of China SXT Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out China SXT Backtesting, China SXT Valuation, China SXT Correlation, China SXT Hype Analysis, China SXT Volatility, China SXT History as well as China SXT Performance.
  
As of November 22, 2024, Price To Sales Ratio is expected to decline to 0.71. The current year's Price Earnings Ratio is expected to grow to -0.44. Please specify China SXT's target price for which you would like China SXT odds to be computed.

China SXT Target Price Odds to finish below 0.48

The tendency of China Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.48  after 90 days
 0.39 90 days 0.48 
about 12.12
Based on a normal probability distribution, the odds of China SXT to stay under $ 0.48  after 90 days from now is about 12.12 (This China SXT Pharmaceuticals probability density function shows the probability of China Stock to fall within a particular range of prices over 90 days) . Probability of China SXT Pharmaceuticals price to stay between its current price of $ 0.39  and $ 0.48  at the end of the 90-day period is about 9.4 .
Given the investment horizon of 90 days China SXT Pharmaceuticals has a beta of -0.71. This usually implies as returns on the benchmark increase, returns on holding China SXT are expected to decrease at a much lower rate. During a bear market, however, China SXT Pharmaceuticals is likely to outperform the market. Additionally China SXT Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   China SXT Price Density   
       Price  

Predictive Modules for China SXT

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as China SXT Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.467.04
Details
Intrinsic
Valuation
LowRealHigh
0.020.376.95
Details
Naive
Forecast
LowNextHigh
0.010.346.92
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.350.440.53
Details

China SXT Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. China SXT is not an exception. The market had few large corrections towards the China SXT's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold China SXT Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of China SXT within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.1
β
Beta against Dow Jones-0.71
σ
Overall volatility
0.12
Ir
Information ratio -0.19

China SXT Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of China SXT for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for China SXT Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
China SXT generated a negative expected return over the last 90 days
China SXT has high historical volatility and very poor performance
China SXT has some characteristics of a very speculative penny stock
China SXT has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.93 M. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 1.25 M.
China SXT Pharmaceuticals currently holds about 15.52 M in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
China SXT has a frail financial position based on the latest SEC disclosures
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: SXTC stock hits 52-week low at 0.43 amid sharp annual decline - Investing.com UK

China SXT Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of China Stock often depends not only on the future outlook of the current and potential China SXT's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China SXT's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding867.4 K
Cash And Short Term Investments12.1 M

China SXT Technical Analysis

China SXT's future price can be derived by breaking down and analyzing its technical indicators over time. China Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of China SXT Pharmaceuticals. In general, you should focus on analyzing China Stock price patterns and their correlations with different microeconomic environments and drivers.

China SXT Predictive Forecast Models

China SXT's time-series forecasting models is one of many China SXT's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary China SXT's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about China SXT Pharmaceuticals

Checking the ongoing alerts about China SXT for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for China SXT Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
China SXT generated a negative expected return over the last 90 days
China SXT has high historical volatility and very poor performance
China SXT has some characteristics of a very speculative penny stock
China SXT has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.93 M. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 1.25 M.
China SXT Pharmaceuticals currently holds about 15.52 M in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
China SXT has a frail financial position based on the latest SEC disclosures
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: SXTC stock hits 52-week low at 0.43 amid sharp annual decline - Investing.com UK
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(3.53)
Revenue Per Share
2.223
Quarterly Revenue Growth
0.295
Return On Assets
(0.05)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.